- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lymphodepletion
Total 35 results
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Kyverna TherapeuticsNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive
-
Baylor College of MedicineTexas Children's Cancer CenterRecruitingLeukemia, B-CellUnited States
-
University College, LondonActive, not recruitingBurkitt Lymphoma | Acute Lymphoblastic LeukemiaUnited Kingdom
-
Century Therapeutics, Inc.Not yet recruitingSystemic Lupus Erythematosus
-
Washington University School of MedicinePaula C. & Rodger O. Riney Blood Cancer ResearchNot yet recruitingMultiple MyelomaUnited States
-
Century Therapeutics, Inc.RecruitingAggressive Non-Hodgkin Lymphoma | R/R CD19-Positive B-Cell Malignancies | Indolent Non-Hodgkin LymphomaUnited States
-
Myeloid TherapeuticsSuspendedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Lymphoma, T-Cell, Peripheral | Cell Therapy | Adoptive Cellular ImmunotherapyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma (DLBCL)United States, Japan, Australia, Italy, Canada, Germany, Norway, Netherlands, France, Austria
-
Novartis PharmaceuticalsCompletedNon-Hodgkin LymphomaJapan, Spain, Germany, Australia, Austria, Canada, Italy, Norway, United States, United Kingdom, Finland, France, Denmark, Netherlands
-
National University Hospital, SingaporeNot yet recruitingOther Solid Tumors | HER2+ Advanced Breast Cancer
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Iovance Biotherapeutics, Inc.Active, not recruitingMetastatic MelanomaUnited States
-
AvenCell Europe GmbHAllucentRecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryGermany
-
Stanford UniversityKyverna TherapeuticsRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Kyverna TherapeuticsNot yet recruitingGeneralized Myasthenia Gravis | Myasthenia Gravis
-
AbbVieIronwood Pharmaceuticals, Inc.Active, not recruitingIrritable Bowel Syndrome With Constipation | Functional ConstipationUnited States, Belgium, Bulgaria, Canada, Estonia, Israel, Italy, Netherlands, Poland, Puerto Rico, Spain, Ukraine, United Kingdom, Germany
-
Kyverna TherapeuticsRecruitingLupus Nephritis | Lupus Nephritis - WHO Class IV | Lupus Nephritis - WHO Class IIIGermany
-
Kyverna TherapeuticsRecruitingLupus Nephritis | Lupus Nephritis - World Health Organization (WHO) Class III | Lupus Nephritis - WHO Class IVUnited States
-
CelgeneCompletedLymphoma, Non-Hodgkin | Precursor Cell Lymphoblastic Leukemia-LymphomaSpain, Netherlands, United States, France, Germany, Italy
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | High Grade B-Cell Non-Hodgkin's Lymphoma | Intermediate Grade B-Cell Non-Hodgkin's LymphomaUnited States
-
Novartis PharmaceuticalsActive, not recruitingNon-Hodgkin LymphomaSpain, Taiwan, Australia, Belgium, Germany, Italy, Singapore, Austria, France, Switzerland, Hong Kong, United States, Netherlands, Norway, United Kingdom, Brazil, China, Japan
-
Jennifer Crombie, MDMerck Sharp & Dohme LLCRecruitingPrimary Mediastinal Large B-cell Lymphoma (PMBCL) | Primary Mediastinal Large B Cell Lymphoma | T-Cell/Histiocyte-Rich Large B-Cell Lymphoma | Primary Mediastinal Large B-Cell Lymphoma Refractory | Primary Mediastinal Large B-Cell Lymphoma Recurrent | Epstein-Barr Virus Positive Diffuse Large...United States
-
Malaghan Institute of Medical ResearchWellington Zhaotai Therapies Limited (WZTL)RecruitingMantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Lymphomas Non-Hodgkin's B-Cell | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL)New Zealand
-
Janssen Scientific Affairs, LLCCompletedMultiple MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic MelanomaMetastatic MelanomaUnited States
-
Patrick C. Johnson, MDAstraZenecaRecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma (DLBCL) | Grade 3b Follicular Lymphoma | Refractory Aggressive B-cell Lymphomas | Aggressive B-cell NHL | De Novo or Transformed Indolent B-cell Lymphoma | DLBCL, Nos Genetic Subtypes | T Cell/Histiocyte-rich Large B-cell Lymphoma and other conditionsUnited States
-
University of FloridaAccelerate Brain Cancer Cure; Lyla Nsouli FoundationActive, not recruitingBrain Stem Glioma | Diffuse Intrinsic Pontine Glioma (DIPG)United States
-
Vall d'Hebron Institute of OncologyBanc de Sang i TeixitsRecruiting
-
M.D. Anderson Cancer CenterBellicum Pharmaceuticals, Inc.Not yet recruitingColorectal Cancer | Minimal Residual DiseaseUnited States
-
Inge Marie SvaneCompleted
-
Janssen Pharmaceutica N.V., BelgiumTerminated
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingMetastatic MelanomaUnited States
-
Novartis PharmaceuticalsRecruitingFollicular Lymphoma (FL)Australia, Korea, Republic of, Spain, Singapore, Poland, Taiwan, Hungary, Romania, Slovakia